(Q43726770)

26 November 2017

Glutamate release promotes growth of malignant gliomas (English)

1 reference

26 November 2017

Takano T

1

1 reference

26 November 2017

Lin JH

2

1 reference

26 November 2017

Arcuino G

3

1 reference

26 November 2017

Gao Q

4

1 reference

26 November 2017

Yang J

5

1 reference

26 November 2017

Nedergaard M

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

7

1 reference

26 November 2017

1010-1015

1 reference

26 November 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0901-1010

26 November 2017

0 references

cites work

Gene therapy of experimental brain tumors using neural progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Epilepsy and brain tumors: implications for treatment

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Rat C6 and human astrocytic tumor cells express a neuronal type of glutamate transporter

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Astrocytic gap junctions remain open during ischemic conditions.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Direct signaling from astrocytes to neurons in cultures of mammalian brain cells.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Localization of neuronal and glial glutamate transporters

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Imaging extracellular waves of glutamate during calcium signaling in cultured astrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Gap-junction-mediated propagation and amplification of cell injury.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Evaluation of memantine for neuroprotection in dementia

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Trauma and the localization of tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Neuronal regulation of glutamate transporter subtype expression in astrocytes.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

The course of seizure disorders in patients with malignant gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Glutamate as a neurotransmitter in the brain: review of physiology and pathology

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

The changing landscape of ischaemic brain injury mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER)

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

The low-affinity, use-dependent NMDA receptor antagonist AR-R 15896AR. An update of progress in stroke

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Astrocyte-mediated potentiation of inhibitory synaptic transmission.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1010

7 January 2021

Identifiers

DOI

10.1038/NM0901-1010

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference